intratumoral therapy

SHELTON, Conn., July 15, 2026 Intensity Therapeutics, Inc. has restarted patient treatment in its Phase 2 INVINCIBLE-4 clinical trial...

JERUSALEM, May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its ReSTART pivotal clinical...